• About
  • Contact
  • Resources
  • Book Nook
Donate
  • Featured
  • Commentary
  • Science & News
  • Mainstream
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Michael Lerner’s Blog
    • Guest Authors
MenuClose
  • Featured
  • Commentary
  • Science & News
  • Mainstream Solutions
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative Therapies
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Guest Authors
    • Michael Lerner’s Blog
  • About
  • Contact
  • Resources
  • Donate

Molly Walker


CDC Peels Off Mask Recommendations for Most U.S. Counties

CDC Peels Off Mask Recommendations for Most U.S. Counties

by Covid Strategies | Feb 25, 2022 | Featured, Science & News

— New guidance to focus more on risk of severe disease versus cases alone by Molly Walker After much speculation, CDC unveiled its new criteria on Friday for masking throughout communities based on healthcare indicators, where only 30% of the country would currently...

read more
Ivermectin Flops Again for COVID, This Time in High-Risk Adults

Ivermectin Flops Again for COVID, This Time in High-Risk Adults

by Covid Strategies | Feb 18, 2022 | Controversies, Featured, Ivermectin

— Malaysian trial finds no difference in progression to severe disease over standard of care by Molly Walker Ivermectin failed to prevent older adults with COVID-19 from progressing to severe disease compared with standard of care alone, an open-label randomized trial...

read more
Which Fully Vaccinated Adults Are Most at Risk of Severe COVID?

Which Fully Vaccinated Adults Are Most at Risk of Severe COVID?

by Covid Strategies | Jan 6, 2022 | Science & News, Vaccines

— Study examines which factors did, and didn't, play a role in risk by Molly Walker A significant proportion of all fully vaccinated adults who died of COVID-19 had at least four risk factors associated with severe outcomes, researchers found. In addition to older age...

read more
Is a ‘Boosters for All’ Strategy the Best Approach?

Is a ‘Boosters for All’ Strategy the Best Approach?

by Covid Strategies | Nov 9, 2021 | Featured, Mainstream Prevention, Mainstream Solutions, Vaccines

— Experts outline three better ways to use limited resources by Molly Walker The resources used to implement a "boosters for all" COVID-19 strategy may be better invested in promoting initial vaccine uptake or increasing access to rapid testing, experts argued....

read more
CDC: Prior Infection Won’t Protect You From COVID Hospitalization

CDC: Prior Infection Won’t Protect You From COVID Hospitalization

by Covid Strategies | Oct 29, 2021 | Featured, Mainstream Prevention, Mainstream Solutions, Vaccines

— Study shows importance of vaccination to prevent severe disease, even among previously infected by Molly Walker n people hospitalized for COVID-like respiratory illnesses, unvaccinated adults who previously had COVID-19 were over five times more likely to test...

read more
FDA Greenlights ‘Mix and Match’ COVID Boosters

FDA Greenlights ‘Mix and Match’ COVID Boosters

by Covid Strategies | Oct 20, 2021 | Mainstream Prevention, Mainstream Solutions, Vaccines

— Moderna, Johnson & Johnson boosters also get thumbs up by Molly Walker The FDA authorized booster doses of Moderna and Johnson & Johnson's COVID-19 vaccines and also authorized a "mix and match" or heterologous approach to boosters for all three available...

read more
First U.S. ‘Mix and Match’ COVID Booster Data Are In

First U.S. ‘Mix and Match’ COVID Booster Data Are In

by Covid Strategies | Oct 14, 2021 | Featured, Mainstream Prevention, Mainstream Solutions, Vaccines

— Researchers urge caution, but a clearer picture starts to emerge by Molly Walker A so-called "mix and match" COVID vaccine series using a different booster than the primary series was safe and produced an increase in immune response comparable to or greater than...

read more
Remdesivir Appears Effective in COVID Outpatients, Too

Remdesivir Appears Effective in COVID Outpatients, Too

by Covid Strategies | Oct 1, 2021 | Mainstream Solutions, Mainstream Treatment, Repurposed Drugs

— But enrollment halted early, and few patients were actually hospitalized by Molly Walker Remdesivir (Veklury) reduced risk of hospitalizations by 87% compared with placebo in outpatients at high risk of progression to severe COVID-19, a researcher said. While the...

read more
FDA Panel Backs Pfizer Booster for Select Groups

FDA Panel Backs Pfizer Booster for Select Groups

by Covid Strategies | Sep 17, 2021 | Mainstream Prevention, Mainstream Solutions, Vaccines

— Advisors overwhelmingly support authorization, but shot down full approval bid by Molly Walker An FDA advisory panel recommended emergency use authorization (EUA) of a booster dose of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty) for individuals 65 and older, and...

read more
Debate Is Over: COVID Vax Doubled Protection for the Previously Infected

Debate Is Over: COVID Vax Doubled Protection for the Previously Infected

by Covid Strategies | Aug 6, 2021 | Integrative Therapies, Mainstream Prevention, Vaccines

— "If you have had COVID-19 before, please still get vaccinated," says CDC Director by Molly Walker Unvaccinated adults who were previously infected with COVID-19 were twice as likely to be reinfected as those previously infected but also fully vaccinated, researchers...

read more
Monoclonal Antibody Cocktail Authorized for Post-COVID Exposure

Monoclonal Antibody Cocktail Authorized for Post-COVID Exposure

by Covid Strategies | Jul 30, 2021 | Integrative Therapies, Integrative Treatments

REGEN-COV becomes first monoclonal antibody treatment with EUA following exposure alone By Molly Walker FDA expanded the emergency use authorization (EUA) for the monoclonal antibody cocktail casirivimab and imdevimab, to include post-exposure prophylaxis (PEP) among...

read more

Address:

Commonweal P.O Box 316 | Bolinas, CA 94924

Latest Covid news in your inbox!

Success!

Subscribe

Search Articles

©2021 CovidStrategies/Commonweal | Site maintained by Mercury Multimedia

Privacy Policy | Home